Viriom Ltd is a young innovative company that was established in 2009 as company for development of targeted medicines for HIV/AIDS treatment. Roche and Viriom Ltd., Member of The Center for Innovative Technologies ChemRar, Russia, have signed a licence agreement granting Viriom development and commercialization rights for potential novel treatments developed by Roche.